[
    [
        {
            "time": "",
            "original_text": "沃森生物贱卖上海润泽背后：资产剥离时机和交易估值皆存疑 资产异常",
            "features": {
                "keywords": [
                    "沃森生物",
                    "贱卖",
                    "上海润泽",
                    "资产剥离",
                    "交易估值",
                    "资产异常"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物贱卖上海润泽背后：资产剥离时机和交易估值皆存疑 资产异常",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "2021年医药生物行业策略报告：聚焦黄金赛道 寻找疫后高光",
            "features": {
                "keywords": [
                    "2021年",
                    "医药生物",
                    "行业策略",
                    "黄金赛道",
                    "疫后高光"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2021年医药生物行业策略报告：聚焦黄金赛道 寻找疫后高光",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        }
    ]
]